Eckert & Ziegler Strahlen- und Medizintechnik AG
Eckert & Ziegler Strahlen- und Medizintechnik AG, through its subsidiaries, provides isotope technology components for medical, scientific, and industrial use worldwide. It operates through three segments: Radiation Therapy, Radiopharma, and Isotope Products. The Radiation Therapy segment develops, manufactures, markets, and sells radioactive products for cancer therapy. This segment offers small radioactive implants for the treatment of prostate cancer seeds; and tumor radiation devices and eye applicators. This segment's products and equipment are used by oncologists, radiotherapists, urologists, ophthalmologists, and medical physicists. The Radiopharma segment operates in the field of molecular imaging and nuclear medicine; and supplies various radiopharmaceuticals, radiochemicals, and related equipment for the synthesis and radiochromatography of PET/SPECT tracers and other radioisotopes. This segment provides products in the categories of radiosynthesis technology, radiochromatography, and radionuclides. The Isotope Products segment offers sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration, and environmental monitoring sources and solutions; and bulk radioisotopes for pharmaceutical, therapeutic, and industrial product manufacturers. It also provides custom and one-off design and manufacturing services. In addition, the company offers services for collection, recycling, and disposal of sealed radioactive sources and low activity isotope related waste from hospitals, research institutes, and industries. Eckert & Ziegler Strahlen- und Medizintechnik AG was founded in 1992 and is headquartered in Berlin, Germany. Show More...
-
Website http://www.ezag.com
-
Sector Healthcare
-
Industry Medical Devices
-
Last Quote 59.80 EUR
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share EUR 1.81 1.98 1.95 1.71 1.28 2.03 1.81 2.78 3.12 4.29 4.13 Dividends EUR 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.8 1.2 1.2 Payout Ratio % * 30.1 36.6 33.5 37.7 31.0 34.1 21.0 26.9 28.0 29.1 Shares Mil 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 5.0 Book Value Per Share * EUR 12.81 13.92 15.16 15.26 16.68 18.29 19.52 20.78 22.69 26.43 27.91 Free Cash Flow Per Share * EUR 3.35 -0.23 0.18 2.72 1.78 4.94 2.89 5.97 Return on Assets % 6.14 6.98 6.46 5.29 3.7 5.58 4.82 7.06 7.23 8.75 8.04 Financial Leverage (Average) 2.11 2.03 2.03 2.14 2.11 1.97 1.9 1.93 1.87 1.98 1.91 Return on Equity % 13.01 14.45 13.15 11.07 7.87 11.39 9.32 13.52 13.73 16.88 15.54 Return on Invested Capital % 11.55 13.11 12.1 8.88 7.27 10.42 8.8 13.11 13.94 16.1 13.97 Interest Coverage 6.7 8.0 7.25 11.89 8.25 11.54 12.01 20.69 35.06 29.54 29.89 Current Ratio 2.17 2.4 2.11 2.28 1.82 2.26 2.79 3.41 3.57 3.36 3.77 Quick Ratio 1.62 1.75 1.48 1.56 1.06 1.35 1.78 2.45 2.49 2.49 2.79 Debt/Equity 0.23 0.17 0.12 0.21 0.08 0.05 0.04 0.12 0.12